The Growth in the flow cytometry market is largely driven by the rising global incidence and prevalence of HIV/AIDS and cancer, growing adoption of flow cytometry techniques in research and academia, growing public-private initiatives in the fields of immunology and immuno-oncology research, technological advancements, increasing incorporation of AI platforms in flow cytometry workflows, and increasing advancements in flow cytometry software. However, the high cost of flow cytometry products is a major factor hampering the growth of the market.
The flow cytometry market is expected to register a CAGR of 8.1% to reach USD 6.3
Billion in 2026 from USD 4.3 Billion in 2021.
Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584
Scope
of the Report
This research report categorizes the flow cytometry
market based on technology, product and service, application, end user, and
region.
By Technology
- Cell-based Flow Cytometry
- Bead-based Flow Cytometry
By Product and
Service
- Reagents and Consumables
- Instruments
- Cell Analyzers
- High-range
- Mid-range
- Low-range
- Cell Sorters
- High-range
- Mid-range
- Low-range
- Services
- Software
- Accessories
By Application
- Research Applications
- Pharmaceuticals and Biotechnology
- Drug Discovery
- Stem Cell Research
- In Vitro Toxicity Testing
- Immunology
- Cell Sorting
- Apoptosis
- Cell Cycle Analysis
- Cell Viability
- Cell Counting
- Other Research Applications
- Clinical Applications
- Cancer
Diagnostics
- Hematology
- Autoimmune
Diseases
- Organ Transplantation
- Other Clinical Applications
- Industrial Applications
By End User
- Academic & Research Institutes
- Hospitals & Clinical Testing Laboratories
- Pharmaceutical & Biotechnology Companies
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of the Asia Pacific (RoAPAC)
- Latin America
- Brazil
- Mexico
- Rest of Latin America (Rest of LATAM)
- Middle East and Africa
Market Segmentation:-
On the basis of technology, the global flow
cytometry market is segmented into cell-based and bead-based flow cytometry.
The bead-based flow cytometry segment is estimated to witness the highest
growth during the forecast period. This technology offers various procedural
advantages over other cell-based assays, such as the capacity to detect multiple
analytes (also known as multiplexing), high reproducibility, stability, and
speed.
In this report, the flow cytometry market for
clinical applications is segmented into organ & tissue transplantations,
cancer diagnostics, immunodeficiency diseases, hematology, and other clinical
applications. Flow cytometry can be applied to cancer studies at every stage by
measuring the amount of DNA in cancer cells, analyzing tumor cell
proliferation, and immunophenotyping hematological malignancies. In addition, flow
cytometry tools are used to determine the malignancy of a tumor by analyzing
and enumerating a number of chromosomes and can thus be used to detect
cancerous cells.
Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=65374584
Regional Analysis: -
In 2020, the Asia
Pacific region accounted for the fasted growing region
of the market. The APAC market is expected to offer significant growth opportunities
to key market players during the forecast period. Countries in this region are
witnessing sustained growth in their GDPs and the disposable incomes of their
middle-class population.
Top Key Players: -
The major players operating in the flow cytometry
market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo
Fisher Scientific, Inc. (US), Luminex Corporation (US), Agilent Technologies,
Inc. (US), Sony Group Corporation (Japan),
Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany),
Enzo Biochem, Inc. (US), Sysmex Corporation (Japan),
bioMérieux S.A. (France),
Cytonome/ ST, LLC (US), Sartorius AG (Germany),
Cytek Biosciences, Inc. (US), Union Biometrica, Inc. (US), Apogee Flow Systems
Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip
Biotechnologies, Co., Ltd. (Japan),
NEXCELOM BIOSCIENCE LLC (US), BennuBio Inc. (US), ORFLO Technologies (US), Bay
Biosciences Co., Ltd. (Japan),
BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands).
No comments:
Post a Comment